Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Archives
    • Special Issue Archive
    • Ahead of Print
    • Abstracts In Press
    • Subject Collections
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Archives
    • Special Issue Archive
    • Ahead of Print
    • Abstracts In Press
    • Subject Collections
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook

The Effect of Video Directly Observed Therapy on Stigma Levels in Tuberculosis Patients

Gokce Celik Kara; Bektas Murat Yalcin

Corresponding Author: Bektas Murat Yalcin; Ondokuz Mayıs University - Department of Family Medicine.

Contact Email: myalcin@omu.edu.tr

Section: Original Research

Publication Date: TBD

AIM: to investigate the effect of video directly observed therapy (VDOT) on stigma levels in tuberculosis (TB) patients.

MATERIAL AND METHODS: Thirty TB patients (36.5%) receiving directly observed therapy (DOT) and 52 receiving VDOT (63.4%) between 15.08.2021 and 15.10.2021 in Samsun, Turkey, were included in this study (n=82). All the participants completed the Stigma Scale in Patients with Tuberculosis (SSTB), and their demographic and disease characteristics were investigated.

RESULTS: The mean age of the participants was 50.0±17.8 years, 64 were married (78.8%), and 38 were women (46.3%) in the study group. Sixty patients had pulmonary TB (73.1%), and duration of disease was less than six months in 64 (82.9) patients. The mean SSTB score was 84.2±12.3, the DOT group exhibiting higher SSTB scores then the VDOT group (t=2.524, p=.006). The VDOT group had lower mean SSTB sub-dimension mean scores (perceived stigma, self-perception internalized stigma, and family/friend relations) (p<0.05). Linear regression models identified VDOT and male gender as independent factors for increased total SSTB scores (p<0.05). VDOT was also identified as an independent factor for total SSTB sub-dimension scores in the linear regression models (p<0.05).

CONCLUSION: Our results confirm that TB patients who receive VDOT has less stigmata compared to homecare DOT. 

ABSTRACTS IN PRESS

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us

© 2022 American Board of Family Medicine

Powered by HighWire